Imaging and Nanomedicine for Diagnosis and Therapy in the Central Nervous System: Report of the Eleventh Annual Blood-Brain Barrier Disruption Consortium Meeting

References

1. ↵
   Ricci PE, Karis JP, Heiserman JE, et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol 1998;19:407–13

   Abstract
2. ↵
   Delbeke D, Meyerowitz C, Lapidus RL, et al. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 1995;195:47–52

   PubMed
3. ↵
   Spence AM, Muzi M, Graham MM, et al. 2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcome. Clin Cancer Res 2002;8:971–79

   Abstract/FREE Full Text
4. ↵
   Degen JW, Walbridge S, Vortmeyer AO, et al. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 2003;99:893–98

   CrossRefPubMedWeb of Science
5. ↵
   Parney IF, Kunwar S, McDermott M, et al. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 2005;102:267–75

   PubMedWeb of Science
6. ↵
   Croteau D, Walbridge S, Morrison PF, et al. Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg 2005;102:90–97

   CrossRefPubMedWeb of Science
7. ↵
   Muldoon LL, Manninger S, Pinkston KE, et al. Imaging, distribution and toxicity of iron oxide magnetic resonance agents in rat brain and intracerebral tumor. Neurosurgery 2005;57:785–95

   PubMedWeb of Science
8. ↵
   Muldoon LL, Varallyay P, Kraemer DF, et al. Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat. Neuropathol Appl Neurobiol 2004;30:70–79

   CrossRefPubMedWeb of Science
9. ↵
   Christoforidis GA, Kangarlu A, Abduljalil AM, et al. Susceptibility-based imaging of glioblastoma microvascularity at 8 T: correlation of MR imaging and postmortem pathology. AJNR Am J Neuroradiol 2004;25:756–60

   Abstract/FREE Full Text
10. ↵
    Dashner RA, Chakeres DW, Kangarlu A, et al. MR imaging visualization of the cerebral microvasculature: a comparison of live and postmortem studies at 8 T. AJNR Am J Neuroradiol 2003;24:1881–84

    Abstract/FREE Full Text
11. ↵
    Neuwelt EA, Várallyay P, Bagó AG, et al. Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumors. Neuropathol Appl Neurobiol 2004;30:456–71

    CrossRefPubMedWeb of Science
12. ↵
    Varallyay P, Nesbit G, Muldoon LL, et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am J Neuroradiol 2002;23:510–19

    Abstract/FREE Full Text
13. ↵
    Manninger SP, Muldoon LL, Nesbit G, et al. An exploratory study of ferumoxtran-10 nanoparticles as a blood brain-barrier imaging agent targeting phagocytic cells in CNS inflammatory lesions. AJNR Am J Neuroradiol 2005;26:2290–300

    Abstract/FREE Full Text
14. ↵
    Frank JA, Anderson SA, Kalish H, et al. Methods for magnetically labeling of stem cells and other cells for detection by in vivo magnetic resonance imaging. Cytotherapy 2004;6:621–25

    CrossRefPubMed
15. ↵
    Arbab AS, Yocum GT, Kalish H, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104:1217–23. Epub 2004 Apr 20

    Abstract/FREE Full Text
16. ↵
    Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Trafficking of magnetically labeled encephalitogenic T-cells in the EAE mouse model by cellular magnetic resonance imaging. Ann Neurol 2004;55:654–59

    CrossRefPubMedWeb of Science
17. ↵
    Anderson SA, Glod J, Arbab AS, et al. Non-invasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005;105:420–25

    Abstract/FREE Full Text
18. ↵
    Zhang Z, Jiang Q, Jiang F, et al. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting brain tumor. Neuroimage 2004;23:281–87

    CrossRefPubMedWeb of Science
19. ↵
    Allport JR, Weissleder R. In vivo imaging of gene and cell therapies. Exp Hematol 2001;29:1237–46

    CrossRefPubMedWeb of Science
20. ↵
    Lockman PR, Mumper RJ, Khan MA, et al. Nanoparticle technology for drug delivery across the blood-brain barrier. Drug Dev Ind Pharm 2002;28:1–13

    CrossRefPubMedWeb of Science
21. ↵
    Qiang Y, Antony J, Marino MG, et al. Synthesis of core-shell nanoclusters with high magnetic moment for biomedical applications. IEEE Transactions on Magnetics 2004;40:3538–40
22. ↵
    Kohler N, Fryxell GE, Zhang M. A bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agents. J Am Chem Soc 2004;126:7206–11

    CrossRefPubMed
23. ↵
    Zhang Y, Kohler N, Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 2002;23:1553–61

    CrossRefPubMedWeb of Science
24. ↵
    Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 2003;278:4135–44. Epub 2002 Nov 25

    Abstract/FREE Full Text
25. ↵
    Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med 2003;9:123–28

    CrossRefPubMed
26. ↵
    Lockman PR, Koziara JM, Roder KE, et al. In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles. Pharm Res 2003;20:705–13

    CrossRefPubMedWeb of Science
27. ↵
    Koziara JM, Lockman PR, Allen DD, et al. In situ blood-brain barrier transport of nanoparticles. Pharm Res 2003;20:1772–78

    CrossRefPubMedWeb of Science
28. ↵
    Koziara JM, Lockman PR, Allen DD, et al. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004;99:259–69

    CrossRefPubMed
29. ↵
    Dernick G, Alvarez De Toledo G, Lindau M. Exocytosis of single chromaffin granules in cell-free inside-out membrane patches. Nat Cell Biol. 2003;5:358–62

    CrossRefPubMedWeb of Science
30. ↵
    Gong LW, Hafez I, Alvarez De Toledo G, et al. Secretory vesicles membrane area is regulated in tandem with quantal size in chromaffin cells. J Neurosci 2003;23:7917–21

    Abstract/FREE Full Text
31. ↵
    An SJ, Almers W. Tracking SNARE complex formation in live endocrine cells. Science 2004;306:1042–46

    Abstract/FREE Full Text
32. ↵
    Dias AF, Dernick G, Valero V, et al. An electrochemical detector array to study cell biology on the nanoscale. Nanotechnology 2002;13:285–89

    CrossRef
33. ↵
    Behanna HA, Donners J, Gordon AC, et al. Coassembly of amphiphiles with opposite peptide polarities into nanofibers. J Am Chem Soc 2005;127:1193–200

    CrossRefPubMedWeb of Science
34. Guler MO, Soukasene S, Hulvat JF, et al. Presentation and recognition of biotin on nanofibers formed by branched peptide amphiphiles. Nano Lett 2005;5:249–52

    PubMed
35. Hartgerink JD, Beniash E, Stupp SI. Peptide-amphiphile nanofibers: a versatile scaffold for the preparation of self-assembling materials. Proc Natl Acad Sci U S A 2002;99:5133–38

    Abstract/FREE Full Text
36. ↵
    Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004;303:1352–55

    Abstract/FREE Full Text
37. ↵
    Zhu J, Wu X, Zhang HL. Adult neural stem cell therapy: expansion in vitro, tracking in vivo and clinical transplantation. Curr Drug Targets 2005;6:97–110

    CrossRefPubMedWeb of Science